Year: 2014
Type: article
Study design: Observational Study
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Amgen, AstraZeneca, GlaxoSmithKline, Sanofi, Gilead Sciences, Teva Pharmaceutical Industries, National Institutes of Health, Genentech, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: G1134233510, Redox-Derived Pulmonary Anti-Inflammatory Mediators, Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma, G2017003252, Amplification of IL-4Ralpha signaling pathways in human airways through 15 LO1, G3724172460, University of Pittsburgh Clinical and Translational Science Institute, G5137401727, University of Pittsburgh Clinical and Translational Science Institute, G6637490487, G7975917069, G860441409, Translational Training Program in Pulmonary Biology and Medicine
OpenAlex ID: W2151306802
